Table 3.
PANSS total | PANSS positive | PANSS negative | PANSS general psychopathology | BACS | SCoRS | SOFAS | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARMS | FES | ARMS | FES | ARMS | FES | ARMS | FES | ARMS | FES | ARMS | FES | ARMS | FES | ||
Saturated | PA | 0.18 | 0.05 | 0.03 | −0.01 | 0.22 | 0.25 | 0.14 | −0.16 | 0.02 | −0.03 | −0.14 | 0.20 | −0.03 | −0.64† |
SA | −0.14 | −0.46 | −0.13 | −0.58† | −0.14 | −0.37 | −0.05 | −0.34 | −0.19 | 0.26 | 0.23 | −0.13 | −0.16 | 0.06 | |
n-9 monounsaturated | OA | −0.12 | 0.71* | −0.07 | 0.25 | −0.10 | 0.63† | −0.17 | 0.61† | 0.11 | −0.60† | 0.11 | 0.08 | −0.06 | −0.14 |
NA | 0.43* | 0.17 | 0.19 | −0.27 | 0.36* | 0.13 | 0.36* | 0.33 | −0.05 | −0.17 | −0.17 | −0.09 | 0.20 | 0.19 | |
n-3 polyunsaturated | EPA | 0.04 | −0.17 | 0.11 | 0.15 | 0.09 | −0.18 | −0.04 | −0.17 | 0.03 | −0.05 | −0.22 | 0.12 | 0.25 | −0.20 |
DPA | 0.12 | 0.03 | 0.18 | −0.14 | 0.13 | 0.01 | 0.05 | 0.17 | 0.13 | −0.39 | −0.10 | −0.20 | 0.08 | 0.25 | |
DHA | 0.20 | 0.01 | 0.14 | 0.10 | 0.18 | −0.05 | 0.15 | 0.15 | 0.02 | −0.29 | −0.20 | 0.27 | 0.24 | 0.21 | |
n-6 polyunsaturated | LA | −0.19 | 0.04 | −0.05 | 0.54† | −0.22 | −0.28 | −0.17 | 0.16 | 0.01 | 0.15 | 0.11 | −0.27 | −0.10 | 0.55† |
DGLA | 0.08 | 0.07 | 0.09 | 0.38 | 0.00 | −0.11 | 0.07 | 0.13 | −0.21 | −0.04 | 0.10 | −0.14 | −0.13 | 0.43 | |
AA | −0.05 | −0.21 | −0.04 | −0.40 | −0.04 | −0.16 | 0.00 | −0.18 | 0.03 | 0.19 | −0.07 | −0.03 | −0.08 | −0.23 | |
summary value | n-3 total | 0.18 | −0.08 | 0.17 | −0.09 | 0.18 | −0.06 | 0.11 | 0.07 | 0.04 | −0.32 | −0.22 | 0.22 | 0.25 | 0.25 |
n-6 total | −0.17 | −0.07 | −0.03 | 0.29 | −0.23 | −0.30 | −0.09 | −0.02 | −0.04 | 0.54† | 0.12 | −0.38 | −0.24 | 0.13 | |
n-6/n-3 ratioa | −0.16 | −0.10 | −0.13 | −0.27 | −0.16 | −0.05 | −0.09 | −0.12 | −0.02 | 0.29 | 0.18 | −0.29 | −0.22 | −0.13 | |
omega-3 indexb | 0.17 | −0.01 | 0.15 | 0.06 | 0.18 | −0.01 | 0.11 | 0.09 | 0.01 | −0.26 | −0.22 | 0.33 | 0.25 | 0.10 |
Values are Spearman’s rho, calculated using semi-partial correlation analysis that only fatty acid indices were controlled by age as a covariate. *False discovery rate adjustment p value < 0.1 (written in bold letters). †There was a significant correlation between fatty acid composition and clinical/cognitive indices, however, they did not survive after post-hoc analysis for multiple comparison. AA, arachidonic acid (20:4 n-6); ARMS, at-risk mental state; BACS, brief assessment of cognition in schizophrenia; DGLA, dihomogammalinolenic acid (20:3 n-6); DHA, docosahexaenoic acid (22:6 n-3); DPA, docosapentaenoic acid (22:5 n-3); EPA, eicosapentaenoic acid (20:5 n-3); FES, first-episode schizophrenia; H, healthy control; LA, linoleic acid (18:2 n-6); NA, nervonic acid (24:1 n-9); OA, oleic acid (18:1 n-9); PA, palmitic acid (16:0); PANSS, positive and negative syndrome scale; SA, stearic acid (18:0); SCoRS, schizophrenia cognition rating scale; SOFAS, social and occupational functioning assessment scale.
n-6/n-3 ratio = AA/(EPA + DHA).
omega-3 index = EPA + DHA.